10000 to 4crs in 18 months 1000rs to 50crs 300% returns 75% promoter holdings A 50 bagger A sureshot 5 bagger Analysis Another fraud? Auto ancillaries Bank sector Blind sell Brand plays Broking Bse Nse Buy calls cements Ceramics/tiles Counters I don't like Debt free businesses Delisting candidates demerger bets Disclosure- I own them Domestic consumption plays E-Commerce pick Education Exit at rallies Famous analysts Famous stocks FMCG Footwear future multibaggers Gems andJewellery Hidden gems High conviction ideas High dividend plays High potential small caps High ROE stocks Holding companies Hotel sector How they looted you.. Indian stock market Infrastructure sector Interesting Microcaps IT KPO Landbank plays largecap ideas Less than 5 PE stocks Liquor Logistics Market lessons Market outlook for 2013 and 2014 Market underperformers Meeting with the CEO Metals Monopoly businesses My 5 baggers My Favourite counters My paid stock recommendations My stock picking techniques nse bse tips Oil exploration Operator calls Paints Penny stock outlook penny stock updates Pharma sector Poultry stocks PSU Publicity freaks Real estate Renewable energy plays Safe bets Sell recommendations Share market Live shipping stocks short term call SOTP plays stock tips stock under 10rs Stocks to watch out for Strong bonus candidates Takeover candidates TATA product tea Textiles The 13 bagger The 45 bagger Trading companies Transformers Turnaround bets Tyres Uncertain/Risky business models Unique businesses

Search This Blog(Over 800 companies covered in the blog).

Archives : Old artciles

Tuesday, October 18, 2011

Sun Pharma Advanced Research Company Ltd:-Buy/sell/growth prospects and recommendation,news and results,target price and analysis,outlook,multibagger

Scripscan:Sun Pharma Advanced Research Company Ltd(SPARC LTD)

Story:Sun Pharma Advance Research Company is India's one of the most innovative companies. This company will hog the limelight sometime in 2012-2013. This stock can definitely be traded during this two-three year gap. Why we are betting on this particular stock is due to a couple of reasons, it is the NCE business Sun 1344H where its competitor's patents are getting expired and Sun 461, the NDDS (new drug delivery system).These two particular molecules have a market potential of over USD 14 billion. I am talking about the entire segment. If this company gets even 5% or 6%, which I feel they can definitely get because of strong promoter group, Sun Pharma, we feel the stock can be a multibagger if someone has the potential to hold this stock from 5-10 years perspective.If I see the potential of the business, if the firm clocks close to Rs 700-800 crore in 2012 which is what we are banking on.The company can easily get in and trade a marketcap to sales ratio of close to 5-6 times. That means at current marketcap of Rs 1800 crore, the company can be double in the next three years.What is more interesting, if someone looks into the entire cycle, there will be some downturns and upturns. The stock has been rangebound for quite sometime in the range of Rs 80-110 level.Recently we have recommended an exit close to Rs 109-110 levels but we would again enter into the stock somewhere close to Rs 80 levels for one simple reason that this stock will definitely be in momentum because of its attractive business in future and also be a trading momentum stock. So from both perspectives, this stock can give humongous returns if someone trades as well as invest into the stock from a longer-term perspective.

Important Disclaimer&Privacy policy

This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.

Subscription to Arunthestocksguru

Enter your email address:

Delivered by FeedBurner